Key points are not available for this paper at this time.
In patients with severe ARDS, early administration of a neuromuscular blocking agent improved the adjusted 90-day survival and increased the time off the ventilator without increasing muscle weakness. (Funded by Assistance Publique-Hôpitaux de Marseille and the Programme Hospitalier de Recherche Clinique Régional 2004-26 of the French Ministry of Health; ClinicalTrials.gov number, NCT00299650.)
Building similarity graph...
Analyzing shared references across papers
Loading...
Laurent Papazian
Jean-Marie Forel
Arnaud Gacouin
New England Journal of Medicine
Inserm
Institut de Neurobiologie de la Méditerranée
Assistance Publique Hôpitaux de Marseille
Building similarity graph...
Analyzing shared references across papers
Loading...
Papazian et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d8fe3bb305d713c2bed905 — DOI: https://doi.org/10.1056/nejmoa1005372